In addition to the most-studied rare risk genes directly participating in amyloidogenesis (such as APP, PSEN1 and PSEN2) for AD, genetic studies have identified dozens of risk genes, which can mostly be classified as participants in the endosomal trafficking pathways, the innate immune response pathways and the cholesterol metabolism pathways [119]. The gene discussed is APP; the disease is Alzheimer disease.